Kansas City Dermatology PA is a clinical research site located in Overland Park, Kansas, United States 66215.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
Kansas City Dermatology PA has participated in 18 clinical trials.
Therapeutic areas: Atopic Dermatitis, Psoriasis, Moderate and Severe Plaque Psoriasis.
Sponsors: Eli Lilly and Company, Genentech, Inc., Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Kansas · View every site in Overland Park
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kansas City Dermatology PA has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kansas City Dermatology PA has 18 clinical trials on record. Their work covers Atopic Dermatitis, Psoriasis, Moderate and Severe Plaque Psoriasis.
Kansas City Dermatology PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.